Survival and delayed effects of risk-stratified hepatoblastoma patients treated in the JPLT-2 trial.
2018
10524Background: The Japanese Study Group for Pediatric Liver Tumor (JPLT) -2 trial (2000-2012) has been conducting to evaluate the efficacy of the CITA regimen, consisting of cisplatin/pirarubicin...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI